Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

BACKGROUND: Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5′ UTR of the FMR1 gene and subsequent DNA methylation of both the expanded sequence and the CpGs of the promoter region. This epigenetic change causes transcriptional silencing of the gene. We have previously de...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabolacci, Elisabetta, Mancano, Giorgia, Lanni, Stella, Palumbo, Federica, Goracci, Martina, Ferrè, Fabrizio, Helmer-Citterich, Manuela, Neri, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806452/
https://www.ncbi.nlm.nih.gov/pubmed/27014370
http://dx.doi.org/10.1186/s13072-016-0060-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806452/
https://www.ncbi.nlm.nih.gov/pubmed/27014370
http://dx.doi.org/10.1186/s13072-016-0060-x

Ejemplares similares